Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus

An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus

(2010) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

(2009) L. Cui et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem

(2009) Y. Katayama et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand

(2009) A. Lulitanond et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis

(2009) B. Limbago et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Genetic Diversity of Staphylocoagulase Genes (coa): Insight into the Evolution of Variable Chromosomal Virulence Factors in Staphylococcus aureus

(2009) Shinya Watanabe et al.   PLoS One

Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus

(2008) B. P. Howden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY